Amid all the controversy over Vytorin this week, Congress's self-appointed Merck/Schering-Plough investigators upped the ante in their probe of the cholesterol drug. Reps. John Dingell and Bark Stupak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results